from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1004c/-

LFCtreatmentdescriptionclass of inhibitor

-0.438

Amikacinug/mL Amikacintranslation

-0.506

Cap5-10ug/mL Capreomycintranslation

0.125

Rox10-50 ug/mL Roxithromycintranslation

-0.296

SM2-5 ug/mL Streptomycintranslation

0.217

Tet5-10 ug/mL Tetracyclinetranslation

1.597

Rif0.2-5ug/mL Rifampicintranscription

-0.301

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.910

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.175

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.211

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.000

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.000

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.498

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.000

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.000

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.000

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.000

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

2.513

Nigericin50 uM Nigericinrespiration

0.192

TRC10-150 ug/mL Triclosanrespiration

0.000

TRZ10-25 ug/mL Thioridazinerespiration

3.505

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.000

menadione6-10 ug/mL Menadionerespiration

0.774

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.836

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.322

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.000

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.000

NRP_1Non-replicating persistence stage 1dosRassociated

0.084

Amp0.2mg/mL AmpicillincellWall

-0.104

Cephalexin20-100 ug/mL CephalexincellWall

-0.991

Cerulenin0.32-5 ug/mL CerulenincellWall

0.219

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.500

EMB10-20 ug/mL EthambutolcellWall

0.274

Eta12-40 ug/mL EthionamidecellWall

0.130

INH0.2-0.4 ug/mL IsoniazidcellWall

0.186

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.000

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.000

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.053

BZA0.12 mg/mL BenzamidearomaticAmides

0.002

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.086

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.503

H2O24 mM hydrogen peroxideDNAdamaging

-0.486

Levo10 ug/mL LevofloxacinDNAdamaging

-0.243

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.000

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.077

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.834

UVUV-irradiationDNAdamaging

0.000

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.924

Antimycin12.5-50 ug/mL Antimycin A?

2.514

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-1.071

PA_110-50 ug/mL Antitubercular compound PA-1?

-1.113

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.323

PA8240.2-2 ug/mL PA-824?

0.258

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.288

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.000

Verapamil50 uM Verapamil?

-2.533

mercaptoethanol2 mM 2-Mercaptoethanol?

0.000

methoxatin10-20 ug/mL Methoxatin?